Matthew Chapin

Matthew Chapin is Sr. VP, Corporate Development at Ora, Inc., the world leader in ophthalmic research and product development services. For the past 18 years, Matt has held positions within Ora across clinical and preclinical development, product strategy, regulatory, marketing and business development. Matt has helped dozens of large pharma and small virtual start-ups transition from preclinical through pre-IND strategy and IND/Phase 2. Matt established Ora Japan KK, was Co-Founder of Aciex Therapeutics, leads several strategic initiatives including structure and management of risk sharing and Co-Development programs, and is currently working on establishing an independent financing vehicle.